• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C.B.17 scid小鼠品系作为人类体内播散性白血病和骨髓瘤的模型。

The C.B.17 scid mouse strain as a model for human disseminated leukaemia and myeloma in vivo.

作者信息

Cattan A R, Douglas E

机构信息

Department of Haematology, University of Newcastle upon Tyne, Royal Victoria Infirmary, U.K.

出版信息

Leuk Res. 1994 Jul;18(7):513-22. doi: 10.1016/0145-2126(94)90089-2.

DOI:10.1016/0145-2126(94)90089-2
PMID:8022201
Abstract

Using the C.B.17 scid mouse strain, we have developed a model of disseminated leukaemia and myeloma using five human cell lines, CCRF-Cem, Molt-4, Raji, IM9 and HS-Sultan. Introduction of any of these cell lines by either an intravenous or an intraperitoneal route eventually kills the mouse due to leukaemia or myeloma cell load. Neoplastic cells can be found in the blood, liver and bone marrow. Intraperitoneal transfer produces a local solid tumour whereas intravenous transfer produces foci of neoplastic cells in the spine and brain. A single dose of melphalan is able to increase survival time from infection of a lethal dose of the T-cell leukaemia cell line, CCRF-Cem.

摘要

利用C.B.17 scid小鼠品系,我们使用5种人类细胞系CCRF-Cem、Molt-4、Raji、IM9和HS-Sultan建立了一种播散性白血病和骨髓瘤模型。通过静脉或腹腔途径引入这些细胞系中的任何一种,最终都会因白血病或骨髓瘤细胞负荷而导致小鼠死亡。肿瘤细胞可在血液、肝脏和骨髓中发现。腹腔转移会产生局部实体瘤,而静脉转移会在脊柱和大脑中产生肿瘤细胞灶。单剂量美法仑能够延长感染致死剂量的T细胞白血病细胞系CCRF-Cem后的存活时间。

相似文献

1
The C.B.17 scid mouse strain as a model for human disseminated leukaemia and myeloma in vivo.C.B.17 scid小鼠品系作为人类体内播散性白血病和骨髓瘤的模型。
Leuk Res. 1994 Jul;18(7):513-22. doi: 10.1016/0145-2126(94)90089-2.
2
A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines.使用人类血液肿瘤细胞系对CB17 scid小鼠模型与四氮唑染料测定法进行比较。
Cancer Chemother Pharmacol. 1996;38(6):548-52. doi: 10.1007/s002800050525.
3
NOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease.NOD/SCID-γ小鼠是评估用于治疗骨髓瘤骨病的治疗药物疗效的理想品系。
PLoS One. 2015 Mar 13;10(3):e0119546. doi: 10.1371/journal.pone.0119546. eCollection 2015.
4
BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation.在与t(4;11)(q21;q23)易位相关的双表型白血病SCID小鼠模型中白血病母细胞的BCL-2表达。
Br J Haematol. 1995 Aug;90(4):855-67. doi: 10.1111/j.1365-2141.1995.tb05207.x.
5
Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.联合使用抗CD7和抗CD38-皂草素免疫毒素治疗人类T细胞急性淋巴细胞白血病,效果显著优于单独使用每种免疫毒素治疗。
Br J Cancer. 2001 Feb;84(4):571-8. doi: 10.1054/bjoc.2000.1633.
6
The use of animal models in multiple myeloma.动物模型在多发性骨髓瘤中的应用。
Morphologie. 2015 Jun;99(325):63-72. doi: 10.1016/j.morpho.2015.01.003. Epub 2015 Apr 17.
7
The SCID mouse environment causes immunophenotypic changes in human immature T-cell lines.严重联合免疫缺陷(SCID)小鼠环境会导致人类未成熟T细胞系发生免疫表型变化。
Int J Cancer. 1994 Feb 15;56(4):546-51. doi: 10.1002/ijc.2910560414.
8
Establishment of a bioluminescent imaging-based in vivo leukemia model by intra-bone marrow injection.通过骨髓内注射建立基于生物发光成像的活体白血病模型。
Int J Oncol. 2012 Dec;41(6):2047-56. doi: 10.3892/ijo.2012.1634. Epub 2012 Sep 20.
9
Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease.人多发性骨髓瘤细胞系在严重联合免疫缺陷病小鼠中的播散性生长。
Cancer Res. 1993 Mar 15;53(6):1392-6.
10
A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease.对目前用于评估治疗药物对肿瘤生长和骨病疗效的多发性骨髓瘤小鼠模型的综述。
Bone. 2015 Aug;77:57-68. doi: 10.1016/j.bone.2015.04.004. Epub 2015 Apr 11.

引用本文的文献

1
"Next top" mouse models advancing CTCL research.推动蕈样肉芽肿研究的“下一代顶级”小鼠模型。
Front Cell Dev Biol. 2024 Apr 10;12:1372881. doi: 10.3389/fcell.2024.1372881. eCollection 2024.
2
The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo.新型去乙酰化酶抑制剂 AR-42 在体外和体内的 B 细胞恶性肿瘤中显示出临床前活性。
PLoS One. 2010 Jun 3;5(6):e10941. doi: 10.1371/journal.pone.0010941.
3
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
FTY720在慢性淋巴细胞白血病和淋巴细胞白血病/淋巴瘤方面展现出了有前景的临床前活性。
Blood. 2008 Jan 1;111(1):275-84. doi: 10.1182/blood-2006-10-053884. Epub 2007 Aug 29.
4
Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice.将通用受体修饰的骨髓移植到SCID小鼠体内后的全身性非T细胞依赖性肿瘤免疫。
J Exp Med. 1996 Dec 1;184(6):2261-9. doi: 10.1084/jem.184.6.2261.